文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

艾伯塔省孕妇产前水痘免疫的经济影响

The economic impact of prenatal varicella immunity among pregnant women in Alberta.
PubMed 文献 · Vaccine · 2016-12-22

研究纳入2002年8月1日至2014年2月2日加拿大艾伯塔省454,592份产前水痘筛查,总体血清阳性率为95.8%。血清阴性独立相关因素包括年龄小于20岁(AOR 4.72)及从非洲或亚洲移民(AOR 4.55和5.83)。40.9%的筛查标本被视为冗余,消除冗余筛查每年可节省约96,000美元实验室和公共卫生随访成本。

要点

  • 产前水痘总体血清阳性率为95.8%。
  • 小于20岁较大于40岁者血清阴性AOR为4.72。
  • 非洲或亚洲移民血清阴性AOR分别为4.55和5.83。

核心结论

  • 孕妇产前水痘血清阳性率高,但年轻年龄和非洲或亚洲移民与血清阴性独立相关。
  • 相当比例产前水痘筛查为冗余,消除冗余筛查可节省实验室和公共卫生随访成本。
  • 随着儿童期普遍接种疫苗带来的疫苗衍生免疫人群增加,筛查方法可能需要调整以确保水痘免疫准确评估。

研究设计与样本

  • 研究纳入2002年8月1日至2014年2月2日加拿大艾伯塔省所有产前水痘筛查试验,共454,592份。
  • 分析检测结果、人口学特征和疫苗接种状态以确定水痘血清阳性率和血清阴性相关因素。
  • 对初始血清阴性且接受产后疫苗接种和接种后产前筛查的2566名女性评估血清转换。

主要发现

  • 所有妊娠筛查中水痘总体血清阳性率为95.8%。
  • 小于20岁较大于40岁者血清阴性的AOR为4.72(95% CI:3.87-5.77)。
  • 从非洲和亚洲移民至艾伯塔省者血清阴性AOR分别为4.55(95% CI:4.10-5.05)和5.83(95% CI:5.48-6.19)。
  • 接种后6个月内检测的女性中66.3%血清阳性,而36个月后检测的女性中仅36.9%血清阳性。
  • 所有产前水痘标本中40.9%被视为冗余,消除冗余筛查每年可节省约96,000美元实验室和公共卫生随访成本。

关键数值与推荐

  • 水痘总体血清阳性率为95.8%。
  • 小于20岁较大于40岁者血清阴性AOR为4.72(95% CI:3.87-5.77)。
  • 非洲移民血清阴性AOR为4.55(95% CI:4.10-5.05),亚洲移民为5.83(95% CI:5.48-6.19)。
  • 接种后6个月内检测者66.3%血清阳性,36个月后检测者36.9%血清阳性。
  • 40.9%的产前水痘标本为冗余,消除后每年可节省约96,000美元。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In light of the changing epidemiology of varicella, we sought to examine varicella antibody levels in the prenatal population in the Canadian province of Alberta. All prenatal varicella screening tests performed between August 1, 2002 and February 2, 2014 (454,592) were included in this study. Test results, demographics and vaccination status were examined to identify varicella seroprevalence and correlates for being seronegative. An overall seroprevalence for varicella of 95.8% was found across all pregnancy screenings. Significant independent correlates of seronegativity included younger age (AOR: 4.72 (95% CI: 3.87-5.77) for <20years of age vs. >40years of age) and having immigrated to Alberta from Africa or Asia (AOR: 4.55 (95% CI: 4.10-5.05) and AOR: 5.83 (95%CI; 5.48-6.19), respectively). Women who were initially seronegative for varicella antibodies and who received both postnatal vaccination and post-vaccination prenatal screening (2566) were examined to assess seroconversion. 66.3% of women who were tested up to six months post-vaccination were seropositive, however only 36.9% of women tested after 36months were seropositive. Finally, 40.9% of all prenatal varicella specimens tested were deemed redundant, i.e. women had either a history of (1) ⩾2 doses of varicella vaccine, (2) varicella infection, or (3) a previous positive varicella serology. Eliminating this redundant screening could provide an estimated $96,000 in savings annually in laboratory and Public Health follow-up costs alone. As the number of women with vaccine-derived immunity through universal childhood vaccination increase in the prenatal population, screening methods may need to adapt to ensure varicella immunity is accurately conducted and assessed.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Passi A, Plitt SS, Lai FY, et al. The economic impact of prenatal varicella immunity among pregnant women in Alberta. Vaccine. 2016. PMID: 28017427. doi:10.1016/j.vaccine.2016.12.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。